Eden Research plc (LON:EDEN) is an AIM-quoted company focussed on sustainable biopesticides and plastic-free encapsulation technology for the use in global crop protection, animal health and consumer products industries.
Biological solutions are the fastest growing segment of the crop protection industry, and Eden is the only UK-listed company with a focus on this market with proven products and a growing business.
Eden’s plant protection products are derived from natural plant chemistry and suitable for a wide range of crops. Used on high-value fruits and vegetables, the product’s efficacy and regulatory status make them ideally suited to solve the challenges faced by growers in today’s increasingly tough regulatory climate.
A key characteristic of Eden’s products is that they are exempt from pesticide residue limits and can be used up to the point of harvest, giving flexibility and security to growers.
In 2020 the global animal health market value is estimated to exceed $33 billion.
Terpenes are well-known as effective treatments for a range of pathogens that affect animal health.
Organisms associated with skin conditions and ear infections can be effectively treated by one or more terpenes. However, upon encapsulation, these same terpenes are generally more effective due to their increased bioavailability and persistence, which is achieved through sustained release.
Steady progress has been made with four products: a shampoo, a conditioner, a spray and an oticetic flush.
Sustaine® has applications in the human health sector where natural chemistries are sought after. Key markets include oral care, human haircare, deodrants and headlice. Eden’s associate, TerpeneTech, has developed and is commercialising its headlice formulation in the UK and USA.
TerpeneTech, which is an associate of Eden through Eden’s shareholding of 29.9%, has been preparing the launch of its headlice treatment product.
Eden’s encapsulated terpene products are highly effective biocides.